AUD/HUF Spot/
| 2024-05-10 9:59:59 PM | Chg. -0.3801 | Volume | Bid9:59:59 PM | Ask9:59:59 PM | High | Low |
|---|---|---|---|---|---|---|
| 237.9101HUF | -0.16% | 49,318 Turnover: 11.73 mill. |
237.8644Bid Size: 1 | 237.9559Ask Size: 1 | 238.3034 | 237.3794 |
GlobeNewswire
04-10
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and Hi...
GlobeNewswire
02-13
Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trade...
GlobeNewswire
2023-10-25
Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorde...
GlobeNewswire
2022-02-22
MediciNova Announces MN-166 (ibudilast) Identified as Promising Pharmacotherapy for Alcohol Use Diso...
GlobeNewswire
2021-12-09
BrainsWay Announces Publication of Deep TMS™ Trial Results for Reduction of Heavy Drinking in Alcoho...
GlobeNewswire
2021-10-26
Soberlink and the National Council of Juvenile and Family Court Judges Create Judge's Bench Card to ...
Newsfile Corp
2021-10-25
International Lithium Corp. Expands Raleigh Lake Lithium and Rubidium project in Ontario, Canada and...
GlobeNewswire
2021-09-30
Adial Pharmaceuticals Announces Greater Than 50% of Patients Expected to Complete ONWARD™ Phase 3 Tr...
GlobeNewswire
2021-08-10
Adial Pharmaceuticals Awarded U.S. and International Patents for the Treatment Of Alcohol and Opioid...
GlobeNewswire
2021-06-22
Adial Pharmaceuticals Plans to Enter Genetic Testing Market Following Allowance of U.S. Patent for G...
GlobeNewswire
2021-06-21
MediciNova Announces Positive Results from Phase 2 Trial of MN-166 (ibudilast) in Alcohol Use Disord...
GlobeNewswire
2021-06-07
Adial Pharmaceuticals Comments on Article in ‘The Atlantic,’ Highlighting the Second Pandemic of Add...
GlobeNewswire
2019-02-26
Adial Pharmaceuticals Announces Closing of $9.2 Million Underwritten Public Offering and Exercise of...
GlobeNewswire
2019-02-21
Adial Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering
GlobeNewswire
2019-02-15
Adial Pharmaceuticals Submits Continuation Patent Application for Use of AD04 in Opioid Dependence a...
GlobeNewswire
2019-02-12
Adial Pharmaceuticals Appoints Leading Addiction Specialist to its Scientific Advisory Board to Adva...
GlobeNewswire
2019-01-17
Adial Pharmaceuticals Appoints Two Additional Global Thought Leaders to its Scientific Advisory Boar...
GlobeNewswire
2018-12-10
Adial Pharmaceuticals Announces Professor Hannu Alho, Emeritus Professor of Addiction Medicine at th...
GlobeNewswire
2018-09-18
Addiction Drug Developer Adial Pharmaceuticals Successfully Passes Patent Opposition Period in Europ...
GlobeNewswire
2018-09-12
Alcohol Use Disorder Drug Candidate from Adial Pharmaceuticals Shows Positive Stability Results
